Quantbot Technologies LP Y M Abs Therapeutics, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$6.57 - $18.69 $29,775 - $84,703	4,532 New	4,532 $73,000
Q2 2023 Aug 08, 2023	BUY	$5.68 - $10.34 $5,112 - $9,306	900 New	900 $6,000
Q1 2022 May 16, 2022	SELL	$6.55 - $17.42 $17,685 - $47,034	-2,700 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$15.51 - $29.31 $32,571 - $61,551	2,100 Added 350.0%	2,700 $43,000
Q3 2021 Nov 09, 2021	BUY	$27.47 - $37.31 $16,482 - $22,386	600 New	600 $17,000
Q1 2021 May 14, 2021	SELL	$29.16 - $51.96 $5,832 - $10,392	-200 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.86 - $54.26 $7,572 - $10,852	200 New	200 $9,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.